JASPER THERAPEUTICS, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-2.8M | $-1.2M | $-9.1M | $-18.7M | $-26.7M | $-21.2M | $-24.3M | $-18.6M |
| Depreciation & Amortization | $21.0K | $21.0K | $290.0K | $229.0K | $258.0K | $279.0K | $285.0K | $500.0K |
| Depreciation | $21.0M | $21.0K | — | — | $300.0K | $300.0K | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $764.0K | $423.0K | $1.7M | $1.4M | $1.8M | $1.8M | $2.0M | $2.0M |
| Net Cash from Operating Activities | $-6.9M | $-14.5M | $-21.9M | $-17.0M | $-15.5M | $-22.8M | $-21.1M | $-14.1M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | $0 | $0 | $1.0K | $4.0K | $-76.0K | $-274.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | — | — | — | — | $345.0K | $9.0K |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — | — | — | — |